| 前收市價 | 4.5400 |
| 開市 | 4.5400 |
| 買盤 | 4.5300 x 200 |
| 賣出價 | 4.5700 x 200 |
| 今日波幅 | 4.4350 - 4.6050 |
| 52 週波幅 | 2.4500 - 5.5450 |
| 成交量 | |
| 平均成交量 | 553,611 |
| 市值 | 488.027M |
| Beta 值 (5 年，每月) | 1.07 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.3500 |
| 業績公佈日 | 2024年8月07日 - 2024年8月12日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 9.25 |
Insider MonkeyMaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript May 11, 2024 MaxCyte, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the MaxCyte First Quarter 2024 Earnings Conference Call. At […]
ZacksMaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
MaxCyte (MXCT) delivered earnings and revenue surprises of 35.71% and 46.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Insider Monkey
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript March 12, 2024 MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.1. MaxCyte, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing […]
